city New Delhi India city Hyderabad covid-19 vaccine Government city New Delhi India city Hyderabad

Covid-19 vaccine: Bharat Biotech to face delays in introduction in US as FDA rejects EUA

Reading now: 864

NEW DELHI : Bharat Biotech International would face a delay in introducing its covid-19 vaccine Covaxin into the United States after USFDA’s rejection for its emergency use authorisation (EUA).Amidst several doubts over its safety and efficacy, the Hyderabad based pharmaceutical company on Friday came into defence of covaxin-- India’s first indigenous covid-19 vaccine—stating that covaxin has received EUA’s from 14 countries with more than 50 countries in the process.“Our US partner, Ocugen has received a recommendation from the FDA to pursue Biologics License Applications (BLA) path for covaxin, which is full approval.

The website is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News